These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 1768205

  • 21. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [Abstract] [Full Text] [Related]

  • 22. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J, Filippa DA, Qin J, Wollner N.
    Cancer; 2003 Sep 15; 98(6):1283-91. PubMed ID: 12973853
    [Abstract] [Full Text] [Related]

  • 23. Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.
    Schrøder H, Kjeldahl M, Boesen AM, Nielsen OJ, Schmidt K, Johnsen HE, Gregersen H, Heyman M, Gustafsson G.
    Dan Med Bull; 2006 Feb 15; 53(1):76-9. PubMed ID: 16761337
    [Abstract] [Full Text] [Related]

  • 24. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
    Jakab Z, Balogh E, Karászi E, Kappelmayer J, Kiss C, Oláh E.
    Med Pediatr Oncol; 2002 Jul 15; 39(1):63-5. PubMed ID: 12116086
    [No Abstract] [Full Text] [Related]

  • 25. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E, Eguchi H, Matsuzaki A, Koga H, Yanai F, Kuroda H, Kawakami K, Ayukawa H, Akiyoshi K, Kamizono J, Tamai Y, Kinukawa N, Okamura J.
    Med Pediatr Oncol; 2001 Jul 15; 37(1):10-9. PubMed ID: 11466717
    [Abstract] [Full Text] [Related]

  • 26. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Ribera JM, Grañena A, Rozman C, Urbano-Ispizua A, Bladé J, Carreras E, Cervantes F, Marín P, Sierra J, Nomdedeu B.
    Sangre (Barc); 1990 Feb 15; 35(1):26-32. PubMed ID: 2333581
    [Abstract] [Full Text] [Related]

  • 27. [Do non-localized non-Hodgkin's lymphoma and acute lymphoblastic leukemia with large tumor masses require the same therapy?].
    Pastore G, Cordero di Montezemolo L, Boschis MP, Ghibaudo P, Saracco P, Miniero R, Madon E, Forni M, Saitta M.
    Haematologica; 1985 Feb 15; 70(4):313-8. PubMed ID: 3935529
    [No Abstract] [Full Text] [Related]

  • 28. [Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
    Schrøder H, Kjeldstad M, Boesen AM, Nielsen OJ, Schmidt KG, Johnsen HE, Gregersen H, Gustafsson G.
    Ugeskr Laeger; 2006 Jun 26; 168(26-32):2554-8. PubMed ID: 16824410
    [Abstract] [Full Text] [Related]

  • 29. [Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)].
    Matsuzaki A, Ishii E, Ueda K, Yanai F, Nibu K, Take H, Koga H, Miyazaki S, Inoue T, Miyake K.
    Rinsho Ketsueki; 1994 Sep 26; 35(9):862-70. PubMed ID: 7967055
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
    Ishii E, Hara T, Ueda K, Kishida K, Nakamura E, Miyazaki S, Yoshida N.
    Rinsho Ketsueki; 1985 Apr 26; 26(4):487-93. PubMed ID: 3862888
    [No Abstract] [Full Text] [Related]

  • 31. [Results of treatment in children with diffuse large cell lymphoma].
    Okamura J, Ikuno Y, Yamada S, Tasaka H, Nibu K, Ikeda N, Kikuchi M.
    Rinsho Ketsueki; 1987 Aug 26; 28(8):1365-9. PubMed ID: 3430752
    [No Abstract] [Full Text] [Related]

  • 32. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A, Zimmermann M, Reiter A, Gadner H, Odenwald E, Harbott J, Ludwig WD, Riehm H, Schrappe M.
    Klin Padiatr; 2005 Aug 26; 217(6):310-20. PubMed ID: 16307416
    [Abstract] [Full Text] [Related]

  • 33. Atypical pyoderma gangrenosum as a manifestation of childhood acute lymphoblastic leukemia.
    Bakhshi S, Sethuraman G, Singh MK, Arya LS.
    Pediatr Dermatol; 2005 Aug 26; 22(6):543-5. PubMed ID: 16354258
    [Abstract] [Full Text] [Related]

  • 34. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
    Desai SJ, Barr RD, Andrew M, deVeber LL, Pai MK.
    CMAJ; 1989 Oct 01; 141(7):693-7. PubMed ID: 2790605
    [Abstract] [Full Text] [Related]

  • 35. p53 expression and poor prognosis in childhood acute lymphoblastic leukemia.
    Hecker S, Sauerbrey A, Volm M.
    Anticancer Res; 1994 Oct 01; 14(6B):2759-61. PubMed ID: 7872714
    [Abstract] [Full Text] [Related]

  • 36. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Ruano D, Diaz MA, Tutor O, Garcia-Sanchez F, Martinez P, Madero L.
    Haematologica; 2000 Aug 01; 85(8):877-8. PubMed ID: 10942942
    [No Abstract] [Full Text] [Related]

  • 37. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Lauten M, Cario G, Asgedom G, Welte K, Schrappe M.
    Haematologica; 2003 Nov 01; 88(11):1253-8. PubMed ID: 14607754
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.